Fundraising FoxKasvutx
1 known investors
Find your way into Kasvutx
Sign up to see every warm intro you have to Kasvutx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kasvutx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kasvu is a drug-discovery company developing small-molecule neuroplastogens — selective positive allosteric modulators of the TrkB receptor — using an AI-powered 3D model of the receptor and structure-based drug design. Its molecules aim to improve neuronal plasticity and cognitive function as treatments for neuropsychiatric conditions and neurodegenerative diseases such as Alzheimer's and Parkinson's.
Founders & leadership
RM
Rafael MolinerCo-Founder & Principal Scientist
JM
Jami MandelinCEO
Investors · 1
Frequently asked questions
- What does Kasvutx do?
- Kasvu is a drug-discovery company developing small-molecule neuroplastogens — selective positive allosteric modulators of the TrkB receptor — using an AI-powered 3D model of the receptor and structure-based drug design. Its molecules aim to improve neuronal plasticity and cognitive function as treatments for neuropsychiatric conditions and neurodegenerative diseases such as Alzheimer's and Parkinson's.
- Who founded Kasvutx?
- Kasvutx was founded by Rafael Moliner.
- Who are Kasvutx's investors?
- Kasvutx's investors include Nordic Science Investments.